Laste Stojanovski
Dundee, SCT DD15EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discovery.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2026
Application of a mouse model humanized for cytochrome P450-mediated drug metabolism to predict drug-drug interactions between a peptide and small molecule drugs.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: June 06, 2025
Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 28, 2023
Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.
Journal: Nature
Published: July 04, 2023
Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of Analogues.
Journal: Journal of medicinal chemistry
Published: June 21, 2023
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs.
Journal: Nature communications
Published: April 12, 2022
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal Trypanosomiasis.
Journal: Journal of medicinal chemistry
Published: March 18, 2022
Identification and development of a series of disubstituted piperazines for the treatment of Chagas disease.
Journal: European journal of medicinal chemistry
Published: February 15, 2022
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target.
Journal: Journal of medicinal chemistry
Published: December 15, 2021
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis.
Journal: Journal of medicinal chemistry
Published: April 27, 2021
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity.
Journal: Journal of medicinal chemistry
Published: July 15, 2020
Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis.
Journal: RSC medicinal chemistry
Published: June 12, 2020
Last Updated: 09/26/2026